Compare KTTA & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KTTA | CYN |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | United States | United States |
| Employees | 5 | 62 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2M | 22.9M |
| IPO Year | N/A | 2021 |
| Metric | KTTA | CYN |
|---|---|---|
| Price | $0.54 | $1.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 436.1K | 222.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $368,138.00 |
| Revenue This Year | N/A | $3,359.28 |
| Revenue Next Year | N/A | $347.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $1.10 |
| 52 Week High | $2.06 | $17.20 |
| Indicator | KTTA | CYN |
|---|---|---|
| Relative Strength Index (RSI) | 35.96 | 37.37 |
| Support Level | $0.49 | N/A |
| Resistance Level | $0.76 | $1.76 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 37.62 | 33.78 |
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.